EATG » Comorbidities

Comorbidities

Twice the rate of bone loss among ART-treated women than men

Bone mineral density declines twice as quickly among HIV-positive women than HIV-positive men, according to Italian research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes.…

Anal high-risk HPV infection more common in HIV-positive MSM

In a new study published in the Journal of Infectious Diseases, Pragna Patel, MD, MPH, and her colleagues set out to characterize the epidemiology of human papillomavirus (HPV) infection in men…

Vitamin D found to be ineffective against ART-related lipid and metabolic dysfunction

Vitamin D has been touted as a preventive treatment or therapy for multiple ailments, from brittle bones to cancer to autoimmune disorders. Several studies have suggested that individuals living with…

CATIE: December 2017 issue of TreatmentUpdate now online

TreatmentUpdate is CATIE’s flagship digest on cutting-edge developments in HIV and hepatitis C research and treatment. TreatmentUpdate 223: Inflammation and HIV, December 2017 issue is available at: http://www.catie.ca/en/treatmentupdate/treatmentupdate-223

Collision of communicable and non-communicable disease epidemics—the case of HIV and COPD

In The Lancet Global Health, Jean Joel Bigna and colleagues report the results of their systematic review and meta-analysis of studies of chronic obstructive pulmonary disease (COPD) in people with…

Shift in HIV-associated kidney disease characterized

Successful antiretroviral therapy for human immunodeficiency virus (HIV) infection has altered the spectrum of HIV-associated kidney disease over the past 30 years, according to the authors of a new review…

Apply to participate in the EATG Ageing Conference NOW

As part of the Ageing with HIV Project, the European AIDS Treatment Group (EATG) is organizing a conference on the topic “New Challenges and Unmet needs of people Living and Ageing…

New survey finds people living with HIV with diarrhea often suffer in silence

A change in the way doctors and patients talk about symptoms could better address this neglected comorbidity in HIV SAN FRANCISCO, December 12, 2017--Napo Pharmaceuticals, Inc. (Napo), a human health…

Marijuana may help HIV patients keep mental stamina longer

A chemical found in marijuana, known as tetrahydrocannabinol, or THC, has been found to potentially slow the process in which mental decline can occur in up to 50 percent of…

Unique pattern of brain inflammation may explain neurocognitive impairment in HIV patients on antiretroviral drugs

Analysis of brains from monkeys infected with simian immunodeficiency virus on antiretroviral therapy suggests unrecognized persistent inflammation may underlie HIV-associated neurocognitive disorders in humans Philadelphia, December 8, 2017 - Although…